Article(id=1330184554771493620, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.07.019, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1660665600000, receivedDateStr=2022-08-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070311490, onlineDateStr=2026-11-19, pubDate=1688918400000, pubDateStr=2023-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070311490, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070311490, creator=13701087609, updateTime=1795070311490, updator=13701087609, issue=Issue{id=1330184417563226564, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='7', pageStart='983', pageEnd='1143', issueExtLink='null', onlineDate='null', pubDate='1688918400000', pubDateStr='2023-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070278778, creator='13701087609', updateTime=1795080510554, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227333488816580, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227333488816581, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1118, endPage=1125, ext={EN=ArticleExt(id=1330184554935071477, articleId=1330184554771493620, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Patent Risk Managements in the Research of Small Molecular Drugs for the Therapy of COVID-19, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Xixiang XIAO, Yanxing TANG, authorsList=Xixiang XIAO, Yanxing TANG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184555220284150, articleId=1330184554771493620, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=治疗新型冠状病毒感染的小分子药物研发中的专利风险管理, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

该文分析了目前全球范围内对严重急性呼吸系统综合征冠状病毒2(SARS-CoV-2)治疗效果显著的小分子药物的专利情况,围绕具体案例的核心专利,阐述了在抗SARS-CoV-2小分子药物研发中的各类知识产权潜在风险类型,以期为我国相关研发人员在抗SARS-CoV-2小分子药物合成、开发过程中管理各类专利侵权风险提供有益的参考。

, authors=肖西祥, 汤艳星, authorsList=肖西祥, 汤艳星, authorCompany=null, correspAuthors=null, authorNote=

肖西祥(1986—),男,本科,副研究员,从事药物专利审查工作。E-mail:

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=ZOEhOf2WV/ROjjvprzERZw==, magXml=55xJtXmrbRYwUyDn5pB7Vw==, pdfUrl=null, pdf=D1h3U0AXhOJo6KaNHfyqSQ==, pdfFileSize=1842964, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=B9OTm9auuNPDD4hiISP2FQ==, mapNumber=null, fund=null)}, authors=[Author(id=1330184555534856955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xxxzsu@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184555614548733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555534856955, language=EN, stringName=Xixiang XIAO, firstName=Xixiang, middleName=null, lastName=XIAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184555719406334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555534856955, language=CN, stringName=肖西祥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555, bio={"content":"

肖西祥(1986—),男,本科,副研究员,从事药物专利审查工作。E-mail:

"}, bioImg=null, bioContent=

肖西祥(1986—),男,本科,副研究员,从事药物专利审查工作。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184555442582263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, xref=null, ext=[AuthorCompanyExt(id=1330184555450970872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555), AuthorCompanyExt(id=1330184555463553785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555)])]), Author(id=1330184555790709504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184555862012674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555790709504, language=EN, stringName=Yanxing TANG, firstName=Yanxing, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184555929121539, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555790709504, language=CN, stringName=汤艳星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184555442582263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, xref=null, ext=[AuthorCompanyExt(id=1330184555450970872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555), AuthorCompanyExt(id=1330184555463553785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555)])])], keywords=[Keyword(id=1330184556017201924, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, language=CN, orderNo=1, keyword=COVID-19), Keyword(id=1330184556080116485, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, language=CN, orderNo=2, keyword=SARS-CoV-2), Keyword(id=1330184556138836742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, language=CN, orderNo=3, keyword=小分子药物), Keyword(id=1330184556193362695, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, language=CN, orderNo=4, keyword=专利风险)], refs=[Reference(id=1330184556273054472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU N, ZHANG D Y, WANG W L, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8): 727-733., articleTitle=null, refAbstract=null), Reference(id=1330184556331774729, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-273., articleTitle=null, refAbstract=null), Reference(id=1330184556390494986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=余悦,邱晓燕,钟明康.新型冠状病毒肺炎治疗药物的最新研发进展[J].中国医药工业杂志,2022,53(6):775-784., articleTitle=null, refAbstract=null), Reference(id=1330184556453409547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=刘烨,明巍,朱园园,等.临床应用中的新型冠状病毒肺炎治疗药物研究进展[J].中国新药杂志,2022,31(20):2022-2028., articleTitle=null, refAbstract=null), Reference(id=1330184556507935500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=黄璐,古双喜.用于COVID-19潜在治疗的小分子药物及专利研究[J].中国医药工业杂志,2020,51(4):467-475., articleTitle=null, refAbstract=null), Reference(id=1330184556570850061, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=卞金磊,张立翱,徐熙,等.治疗新冠肺炎口服小分子药物研究进展[J].中国医药导刊,2022,24(1):16-26., articleTitle=null, refAbstract=null), Reference(id=1330184556629570318, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=OWEN D R, ALLERTON C M N, ANDERSON A S, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 [J]. Science, 2021, 374(6575):1586-1593., articleTitle=null, refAbstract=null), Reference(id=1330184556696679183, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=UNOH Y, UEHARA S, NAKAHARA K, et al. Discovery of S-217622, a noncovalent Oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19 [J]. J Med Chem, 2022, 65(9): 6499-6512., articleTitle=null, refAbstract=null), Reference(id=1330184556755399440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=段传奇,林快乐,周伟澄.口服小分子抗新冠药物莫努匹韦和帕罗韦德合成路线综述[J].中国医药工业杂志,2021,52(12):1549-1560., articleTitle=null, refAbstract=null), Reference(id=1330184556839285521, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=IMRAN M, KUMAR ARORA M, ASDAQ S M B, et al. Discovery, development, and patent trends on molnupiravir:a prospective oral treatment for COVID-19 [J]. Molecules,2021, 26(19): 5795., articleTitle=null, refAbstract=null), Reference(id=1330184556898005778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Y J, CAO L, LI G, et al. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models [J]. J Med Chem, 2022, 65(4): 2785-2793., articleTitle=null, refAbstract=null), Reference(id=1330184556956726035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=YU B, CHANG J B. The first Chinese oral anti-COVID-19 drug Azvudine launched [J]. Innovation(Camb), 2022,3(6): 100321., articleTitle=null, refAbstract=null), Reference(id=1330184557049000724, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=RICHARDSON P, GRIFFIN I, TUCKER C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease [J]. Lancet, 2020, 395(10223):e30-e31., articleTitle=null, refAbstract=null), Reference(id=1330184558626059029, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Pharmacy Times. FDA approves baricitinib for certain adult patients hospitalized with COVID-19 [EB/OL]. [2020-05-11]. https://www.pharmacytimes.com/view/fda-approves-baricitinib-for-certain-adult-patients-hospitalized-with-covid-19., articleTitle=null, refAbstract=null), Reference(id=1330184558709945110, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=李瑞丰,陈燕.专利布局视角下药企应对“专利悬崖”策略研究及思考[J].电子知识产权,2017,(6):64-72., articleTitle=null, refAbstract=null), Reference(id=1330184558768665367, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=曹丽荣.美国生物药专利侵权案例评析及启示—以等同原则适用为视角[J].中国发明与专利,2018,15(12):81-88., articleTitle=null, refAbstract=null), Reference(id=1330184558860940056, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=李敏.前药设计原理及其临床应用[J].中国现代药物应用,2009,3(15):193-195., articleTitle=null, refAbstract=null), Reference(id=1330184558928048921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=XIE Y C, YIN W C, ZHANG Y M, et al. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 [J]. Cell Res, 2021, 31(11): 1212-1214., articleTitle=null, refAbstract=null), Reference(id=1330184558986769178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=彭晓琦,邓声菊.中美前药制备专利侵权风险判定规则初探[J].中国新药杂志,2017,26(8):860-864., articleTitle=null, refAbstract=null), Reference(id=1330184559062266651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=HUGHES D L. Quest for a cure: potential small-molecule treatments for COVID-19, part 2 [J]. Org Process Res Dev,2021, 25(5): 1089-1111., articleTitle=null, refAbstract=null), Reference(id=1330184559154541340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=金泳锋,余 翔.专利风险的特征及其影响研究[J].知识产权,2008,(6):84-88., articleTitle=null, refAbstract=null), Reference(id=1330184559238427421, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=柳春.我国企业预防涉外知识产权纠纷的策略分析[J].未来与发展,2010,32(7):74-77., articleTitle=null, refAbstract=null), Reference(id=1330184559305536286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=董丽,刘文东,杨莉.我国制药企业自主创新不同阶段的专利风险识别[J].中国新药杂志,2014,23(6):635-639., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330184555442582263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, xref=null, ext=[AuthorCompanyExt(id=1330184555450970872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555), AuthorCompanyExt(id=1330184555463553785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.07.019, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.07.019, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.07.019, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.07.019, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1688918400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
治疗新型冠状病毒感染的小分子药物研发中的专利风险管理
肖西祥 , 汤艳星
中国医药工业杂志 | 药学管理与信息 2023,54(7): 1118-1125
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2023 , 54 (7) : 1118 -1125
治疗新型冠状病毒感染的小分子药物研发中的专利风险管理
全屏
[Author(id=1330184555534856955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xxxzsu@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184555614548733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555534856955, language=EN, stringName=Xixiang XIAO, firstName=Xixiang, middleName=null, lastName=XIAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184555719406334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555534856955, language=CN, stringName=肖西祥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555, bio={"content":"

肖西祥(1986—),男,本科,副研究员,从事药物专利审查工作。E-mail:

"}, bioImg=null, bioContent=

肖西祥(1986—),男,本科,副研究员,从事药物专利审查工作。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184555442582263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, xref=null, ext=[AuthorCompanyExt(id=1330184555450970872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555), AuthorCompanyExt(id=1330184555463553785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555)])]), Author(id=1330184555790709504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184555862012674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555790709504, language=EN, stringName=Yanxing TANG, firstName=Yanxing, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184555929121539, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, authorId=1330184555790709504, language=CN, stringName=汤艳星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184555442582263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, xref=null, ext=[AuthorCompanyExt(id=1330184555450970872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555), AuthorCompanyExt(id=1330184555463553785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184554771493620, companyId=1330184555442582263, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家知识产权局专利局专利审查协作广东中心,广东 广州 510555)])])]
肖西祥 , 汤艳星
作者信息
  • 国家知识产权局专利局专利审查协作广东中心,广东 广州 510555
作者简介:

肖西祥(1986—),男,本科,副研究员,从事药物专利审查工作。E-mail:

Patent Risk Managements in the Research of Small Molecular Drugs for the Therapy of COVID-19
Xixiang XIAO , Yanxing TANG
Affiliations
  • Patent Examination Cooperation Guangdong Center of the Patent Office, CNIPA, Guangzhou 510555
出版时间: 2023-07-10 doi: 10.16522/j.cnki.cjph.2023.07.019
文章导航
收藏切换

该文分析了目前全球范围内对严重急性呼吸系统综合征冠状病毒2(SARS-CoV-2)治疗效果显著的小分子药物的专利情况,围绕具体案例的核心专利,阐述了在抗SARS-CoV-2小分子药物研发中的各类知识产权潜在风险类型,以期为我国相关研发人员在抗SARS-CoV-2小分子药物合成、开发过程中管理各类专利侵权风险提供有益的参考。

COVID-19  /  SARS-CoV-2  /  小分子药物  /  专利风险
肖西祥, 汤艳星. 治疗新型冠状病毒感染的小分子药物研发中的专利风险管理. 中国医药工业杂志, 2023 , 54 (7) : 1118 -1125 . DOI: 10.16522/j.cnki.cjph.2023.07.019
Xixiang XIAO, Yanxing TANG. Patent Risk Managements in the Research of Small Molecular Drugs for the Therapy of COVID-19[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (7) : 1118 -1125 . DOI: 10.16522/j.cnki.cjph.2023.07.019

参考文献 引证文献
排序方式:
[1]
ZHU N, ZHANG D Y, WANG W L, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8): 727-733.
[2]
ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-273.
[3]
余悦,邱晓燕,钟明康.新型冠状病毒肺炎治疗药物的最新研发进展[J].中国医药工业杂志,2022,53(6):775-784.
[4]
刘烨,明巍,朱园园,等.临床应用中的新型冠状病毒肺炎治疗药物研究进展[J].中国新药杂志,2022,31(20):2022-2028.
[5]
黄璐,古双喜.用于COVID-19潜在治疗的小分子药物及专利研究[J].中国医药工业杂志,2020,51(4):467-475.
[6]
卞金磊,张立翱,徐熙,等.治疗新冠肺炎口服小分子药物研究进展[J].中国医药导刊,2022,24(1):16-26.
[7]
OWEN D R, ALLERTON C M N, ANDERSON A S, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 [J]. Science, 2021, 374(6575):1586-1593.
[8]
UNOH Y, UEHARA S, NAKAHARA K, et al. Discovery of S-217622, a noncovalent Oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19 [J]. J Med Chem, 2022, 65(9): 6499-6512.
[9]
段传奇,林快乐,周伟澄.口服小分子抗新冠药物莫努匹韦和帕罗韦德合成路线综述[J].中国医药工业杂志,2021,52(12):1549-1560.
[10]
IMRAN M, KUMAR ARORA M, ASDAQ S M B, et al. Discovery, development, and patent trends on molnupiravir:a prospective oral treatment for COVID-19 [J]. Molecules,2021, 26(19): 5795.
[11]
LI Y J, CAO L, LI G, et al. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models [J]. J Med Chem, 2022, 65(4): 2785-2793.
[12]
YU B, CHANG J B. The first Chinese oral anti-COVID-19 drug Azvudine launched [J]. Innovation(Camb), 2022,3(6): 100321.
[13]
RICHARDSON P, GRIFFIN I, TUCKER C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease [J]. Lancet, 2020, 395(10223):e30-e31.
[14]
Pharmacy Times. FDA approves baricitinib for certain adult patients hospitalized with COVID-19 [EB/OL]. [2020-05-11]. https://www.pharmacytimes.com/view/fda-approves-baricitinib-for-certain-adult-patients-hospitalized-with-covid-19.
[15]
李瑞丰,陈燕.专利布局视角下药企应对“专利悬崖”策略研究及思考[J].电子知识产权,2017,(6):64-72.
[16]
曹丽荣.美国生物药专利侵权案例评析及启示—以等同原则适用为视角[J].中国发明与专利,2018,15(12):81-88.
[17]
李敏.前药设计原理及其临床应用[J].中国现代药物应用,2009,3(15):193-195.
[18]
XIE Y C, YIN W C, ZHANG Y M, et al. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 [J]. Cell Res, 2021, 31(11): 1212-1214.
[19]
彭晓琦,邓声菊.中美前药制备专利侵权风险判定规则初探[J].中国新药杂志,2017,26(8):860-864.
[20]
HUGHES D L. Quest for a cure: potential small-molecule treatments for COVID-19, part 2 [J]. Org Process Res Dev,2021, 25(5): 1089-1111.
[21]
金泳锋,余 翔.专利风险的特征及其影响研究[J].知识产权,2008,(6):84-88.
[22]
柳春.我国企业预防涉外知识产权纠纷的策略分析[J].未来与发展,2010,32(7):74-77.
[23]
董丽,刘文东,杨莉.我国制药企业自主创新不同阶段的专利风险识别[J].中国新药杂志,2014,23(6):635-639.
2023年第54卷第7期
21
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.07.019
  • 接收时间:2022-08-17
  • 首发时间:2026-11-19
  • 出版时间:2023-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-08-17
基金
作者信息
    国家知识产权局专利局专利审查协作广东中心,广东 广州 510555
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.07.019
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏